Failing to master International Reference Pricing can translate into poor relationships and weak negotiation positions with governments, as well as missed opportunities amounting to tens of millions of dollars as a result of uncoordinated price changes or product launches.
Model N International Reference Pricing for biopharma manufacturers coordinates global, regional, and country affiliates’ pricing and government affairs teams with a user-friendly, highly configurable Web platform. The solution connects pricing stakeholders globally in real time and around a common pricing repository to optimize pharma pricing and product launch decisions and satisfy regulatory requirements across different geographies.
Launch Optimization: Identify best combinations of launch date and price per country in a select time horizon
Scenario Calculations: Simulate the impact of price events on regional or global revenue; Evaluate mitigation alternatives
Reporting & Analytics: Access price change impact reports, referencing country reports; Create ad-hoc reports and charts
Global Price Governance: Notify affiliates of actual/ expected changes; Trigger notification, acknowledgement, or escalation
Rule Definitions and Calculations: Manage reference pricing rules: countries, formulae, units, channels, formal/informal, etc.
Global Pricing Database: Manage country prices, currency fx rates, volume forecasts in a single global repository
“Before, we changed price without understanding how it might impact other markets strategically. Now, we can understand the risk in every decision."
- EMEA Pricing Director,
Leading Pharma Manufacturer
- (650) 610-4600
- Request Information
Model N not only has demonstrated a deep understanding of the current Medicaid issues, but its integrated suite of applications will provide us with a revenue management platform that can accommodate our growth both in the commercial and government sector.
Associate Director of Distribution,